Jeremy Thurman on May 27, 2011
The Food and Drug Administration (FDA) issued a warning on March 4, 2011 that women who have used Topamax during pregnancy are more likely to have infants with birth defects, including cleft palate, cleft lip, and other facial malformations. Continue reading